The trials were different studies with different populations so they cant be directly compared, McGowan says
(2008) Identification of dopamine D1-D3 receptor heteromers
doi: 10.1021/bi00353a016 Vandenberg, JI, King, GF and Kuchel, PW (1985)
Some patients who experience insomnia on injectable semaglutide find that oral semaglutide, taken in the morning with food, produces fewer sleep disruptions because absorption is gradual and more dispersed throughout the day
i noticed good results pretty fast
Conclusion This study provides preliminary evidence in support of GLP-1 based therapies in providing beneficial effects against atherosclerosis as this therapeutic regimen was found to be associated with statistically significant reductions in the plasma levels of atherosclerosis markers including plasminogen activator inhibitor-1, high sensitivity c-reactive protein and brain natriuretic peptide